To investigate in people with NT1 and matched controls, after an experimentally induced social stress test:Primary:- Direct HPA activation (plasma cortisol).Secondary: - Direct autonomic stress response (ACTH and HR). - HPA activity and autonomic…
ID
Source
Brief title
Condition
- Sleep disturbances (incl subtypes)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Difference between patients with NT1 and matched controls in the mean plasma
cortisol levels after stress exposure (T1), adjusted for baseline plasma
cortisol level (T0).
Secondary outcome
- Differences between patients with NT1 and matched controls in the plasma
cortisol levels after recovery (T2 and T3), adjusted for baseline plasma
cortisol level (T0).
- Differences between patients with NT1 and matched controls in their plasma
ACTH levels after stress exposure (T1) and recovery (T2 and T3), adjusted for
baseline ACTH levels (T0).
- Differences between patients with NT1 and matched controls in HR during all
time points of the experiment.
- Differences in subjectively experienced stress between patients with NT1 and
matched controls at all time points of the experiment.
- Differences between patients with NT1 and matched controls in the association
between objective and subjective stress parameters, and their relationship with
any of the background variables, during all time points of the experiment.
Background summary
Narcolepsy type 1 (NT1) is a very disabling sleep-wake disorder caused by a
cerebral deficiency of hypocretin (Hcrt, also known as orexin). A recent
post-mortem brain study of the hypothalamus in NT1 not only showed a major
reduction of Hcrt cells, but also a 88% reduction of corticotrophin-releasing
hormone (CRH)-positive neurons (Shan et al., 2022) in the paraventricular
nucleus (PVN). CRH in this nucleus is known for its role as
hypothalamic-pituitary-adrenal (HPA) axis activator. This matches with the
earlier finding of reduced basal pituitary adrenocorticotropic hormone (ACTH)
secretion in patients with NT1 (Kok et al., 2002). Therefore it is expected
that patients with NT1 have a lowered cortisol (stress) response compared to
matched controls. Better understanding of the HPA activity in patients with NT1
may give better insights in the effects of lost CRH-positive cells in this
population. This knowledge may contribute to greater understanding of the
etiology of the disease and the development of potential novel treatments in
the future.
Study objective
To investigate in people with NT1 and matched controls, after an experimentally
induced social stress test:
Primary:
- Direct HPA activation (plasma cortisol).
Secondary:
- Direct autonomic stress response (ACTH and HR).
- HPA activity and autonomic stress after a recovery time (plasma cortisol,
ACTH and HR).
- Subjectively experienced stress directly after the stress test and after
recovery time.
- The association between subjective and objective stress markers, and their
relationship with any background variables.
Study design
A quasi-experimental case-control intervention in n=12 patients with NT1 and
n=12 controls matched for age and sex. All participants will be exposed to the
Trier Social Stress Test for Groups (TSST-G) in six groups of four participants
each. Before the TSST-G (T0), directly after (T1), after a 15-minute recovery
period (T2) and after a second 15-minute recovery period (T3), we will assess:
plasma ACTH and cortisol and subjective stress. Heart rate (HR) will be
measured continuously.
Intervention
The TSST-G is an effective stress intervention, where participants are
instructed to give a public speech, followed by a mental arithmetic task,
before a non-supportive jury while thinking they are being videotaped. This
test has shown in previous studies to effectively induce psychophysiological
stress and activate the HPA axis (Von Dawans, Kirschbaum & Heinrichs, 2011).
Study burden and risks
Participants visit the research center once for about 4 hours in total.
Participants are told that they participate in a study about social competence
and resilience. During their visit they will be exposed to a stress test
(TSST-G). In total, four blood samples will be taken via a cannula to avoid the
stress of multiple punctures, which may be unpleasant and induces a regular
(small) risk of local hemorrhage. The subjective questionnaires will take about
15 minutes each time, inducing minimal burden. Potential negative feelings
regarding the TSST-G will be taken away as much as possible during an extensive
debriefing. The TSST-G is a validated test which does not lead to extreme
perceived anxiety levels or burden. Participants will not personally benefit
from this study. They will be compensated with ¤50 for participation. Patients
with NT1 will have the opportunity to take a nap at the research center after
the experiment.
Achterweg 3
Heemstede 2103SW
NL
Achterweg 3
Heemstede 2103SW
NL
Listed location countries
Age
Inclusion criteria
- Age 18-64 years.
- For patient group: a diagnosis of narcolepsy type 1 following the ICSD-3
criteria.
Exclusion criteria
- For control group: any sleep-wake disorder or use of sleep medication
- Any other disease that may affect HPA activity
- History of anxiety disorders, panic attacks, cardiac disease or hypertension,
epilepsy or Cushing*s disease
- Mental retardation
- Current depressive disorder
- Current use of antidepressants (not being low dose for cataplexy)
- Present use of benzodiazepines or any hormonal treatment (other than oral
contraceptives)
- Pregnant or lactating
- Smoking > 5 cigarettes a day
- Excessive alcohol consumption (women >14, men >21 units a week)
- Lack of fluency in the Dutch language or speech impairments
- Experienced public speaker
- Psychologist or study/specialisation psychology
Design
Recruitment
metc-ldd@lumc.nl
metc-ldd@lumc.nl
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL82071.058.22 |